8-Bromo-5-methyl-[1,2,4]triazolo[4,3-a]pyridine
95%
- Product Code: 87725
CAS:
1379355-21-1
Molecular Weight: | 212.0464 g./mol | Molecular Formula: | C₇H₆BrN₃ |
---|---|---|---|
EC Number: | MDL Number: | MFCD16556184 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature, dry, sealed |
Product Description:
This compound is primarily utilized in pharmaceutical research and development due to its unique structure, which makes it a valuable intermediate in the synthesis of various biologically active molecules. It is often employed in the creation of potential drug candidates, particularly for targeting neurological disorders and other conditions where modulation of specific receptors or enzymes is required. Additionally, its triazolopyridine core is explored in the development of novel compounds with potential anti-inflammatory, antimicrobial, or anticancer properties. Its bromo and methyl substituents provide reactive sites for further chemical modifications, enabling the design of diverse derivatives for screening and optimization in drug discovery programs.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.500 | 10-20 days | ฿16,398.00 |
+
-
|
1.000 | 10-20 days | ฿29,520.00 |
+
-
|
8-Bromo-5-methyl-[1,2,4]triazolo[4,3-a]pyridine
This compound is primarily utilized in pharmaceutical research and development due to its unique structure, which makes it a valuable intermediate in the synthesis of various biologically active molecules. It is often employed in the creation of potential drug candidates, particularly for targeting neurological disorders and other conditions where modulation of specific receptors or enzymes is required. Additionally, its triazolopyridine core is explored in the development of novel compounds with potential anti-inflammatory, antimicrobial, or anticancer properties. Its bromo and methyl substituents provide reactive sites for further chemical modifications, enabling the design of diverse derivatives for screening and optimization in drug discovery programs.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :